NEVVI Medicare utilization intelligence

← back

PEREZ-RODRIGUEZ, AUDRIKMD NPI 1831573294 Clinician

Medical Oncology · GARDEN CITY, KS

Specialty Medical Oncology — from billed Medicare claims
In practice about 16 years since medical school (class of 2010, self-reported to CMS)
Location GARDEN CITY, KS · NPPES registered location
Active in data Billed Medicare 2022–2024 (3 consecutive years)
Scale 39 codes billed · 89,112 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20232026
CENTRAL CARE PA
2023–2026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2024-10

Year: 2024 · 2023 · 2022 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Unlock to see the figure.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
Q5125 Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram
J9271 Injection, pembrolizumab, 1 mg
J0897 Injection, denosumab, 1 mg
J9267 Injection, paclitaxel, 1 mg
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J1437 Injection, ferric derisomaltose, 10 mg
J1626 Injection, granisetron hydrochloride, 100 mcg
J1952 Leuprolide injectable, camcevi, 1 mg
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
J9190 Injection, fluorouracil, 500 mg
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
96413 Administration of chemotherapy into vein, 1 hour or less
96372 Injection of drug or substance under skin or into muscle
J9045 Injection, carboplatin, 50 mg
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
J1200 Injection, diphenhydramine hcl, up to 50 mg
96523 Irrigation of implanted venous access drug delivery device
J3475 Injection, magnesium sulfate, per 500 mg
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
96415 Administration of chemotherapy into vein, each additional hour
J9217 Leuprolide acetate (for depot suspension), 7.5 mg
96417 Administration of additional new drug or substance into vein, 1 hour or less
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
96375 Injection of additional new drug or substance into vein
J1454 Injection, fosnetupitant 235 mg and palonosetron 0.25 mg
36415 Insertion of needle into vein for collection of blood sample
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
J7030 Infusion, normal saline solution , 1000 cc
96360 Infusion into a vein for hydration, 31-60 minutes
G0498 Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l
96368 Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion
96361 Infusion into a vein for hydration, each additional hour
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
99211 Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional
99406 Smoking and tobacco use intensive counseling, 4-10 minutes
G0008 Administration of influenza virus vaccine
90653 Influenza vaccine, inactivated

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.